Skip to content
Home
About us
Insights
Stocks
Compliance
Special Services
Contact
Language
EN
BR
EN
EN
BR
Tag:
Anvisa
Insights
Brazil Eyes R$1.5 Billion a Year for GLP-1 Weight-Loss Drugs, Targets Discounts of Up to 90%
September 29, 2026
Insights
Brazil Creates National System to Assess Quality at Private Hospitals and Clinics
September 29, 2026
Insights
Anvisa Approves EMS’s Ozivy, Brazil’s First Semaglutide Pen
May 26, 2026
Insights
Anvisa Reviews Elevidys, a R$20 Million Gene Therapy Suspended in Brazil
April 29, 2026
Behind the Lines
The drug that is drying up consumption
April 15, 2026
Nelson Mussolini
,
Opinion
When State Failure Becomes a Public Health Risk
March 31, 2026
Insights
Lula Expands India Trip With Pharma Fast-Track and Defense Push
February 17, 2026
Insights
Pharma Groups Warn Congress Over Broader Compulsory Licensing
February 11, 2026
Insights
Brazil’s Anvisa Expands Medical Cannabis Rules, Allows Compounding Pharmacies
January 28, 2026
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
